Evoke Pharma and EVERSANA Announce the Appointment of Christopher Quesenberry as Chief Commercial Officer for Gimoti™GlobeNewsWire • 08/25/20
Evoke Receives FDA Conditional Acceptance of Gimoti Brand Name Following NDA ResubmissionGlobeNewsWire • 05/20/20
Evoke Pharma Enters Commercialization Agreement with EVERSANA Life Sciences for Gimoti™GlobeNewsWire • 01/23/20
Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti™GlobeNewsWire • 09/17/19